Ask AI
ProCE Banner Activity

Immune Checkpoint Inhibitor Therapy in the Clinical Management of Pretreated ES-SCLC

Slideset Download
Download this slideset to review the latest data informing optimal use of immune checkpoint inhibition for the treatment of pretreated SCLC, including recommendations for immune-related adverse events.

Released: July 09, 2020

Expiration: July 08, 2021

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Genentech, a member of the Roche Group

Merck Sharp & Dohme Corp.

Faculty Disclosure

Primary Author

Anna F. Farago, MD, PhD

Assistant Professor of Medicine
Department of Medicine
Harvard Medical School
Assistant in Medicine
Division of Hematology/Oncology
Department of Medicine
Massachusetts General Hospital
Boston, Massachusetts

Taofeek K. Owonikoko, MD, PhD

Professor
Department of Hematology and Medical Oncology
Co-Leader, Thoracic Oncology
Emory University
Atlanta, Georgia